21-46119151-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001849.4(COL6A2):​c.1269+32C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0166 in 1,521,670 control chromosomes in the GnomAD database, including 262 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 45 hom., cov: 34)
Exomes 𝑓: 0.016 ( 217 hom. )

Consequence

COL6A2
NM_001849.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.16

Publications

1 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 21-46119151-C-T is Benign according to our data. Variant chr21-46119151-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 258315.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0193 (2941/152276) while in subpopulation AFR AF = 0.0303 (1258/41562). AF 95% confidence interval is 0.0289. There are 45 homozygotes in GnomAd4. There are 1360 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 45 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001849.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A2
NM_001849.4
MANE Select
c.1269+32C>T
intron
N/ANP_001840.3
COL6A2
NM_058174.3
MANE Plus Clinical
c.1269+32C>T
intron
N/ANP_478054.2
COL6A2
NM_058175.3
c.1269+32C>T
intron
N/ANP_478055.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A2
ENST00000300527.9
TSL:1 MANE Select
c.1269+32C>T
intron
N/AENSP00000300527.4
COL6A2
ENST00000397763.6
TSL:5 MANE Plus Clinical
c.1269+32C>T
intron
N/AENSP00000380870.1
COL6A2
ENST00000409416.6
TSL:5
c.1269+32C>T
intron
N/AENSP00000387115.1

Frequencies

GnomAD3 genomes
AF:
0.0193
AC:
2937
AN:
152160
Hom.:
45
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0302
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.0218
Gnomad ASJ
AF:
0.00980
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.00310
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0172
Gnomad OTH
AF:
0.0296
GnomAD2 exomes
AF:
0.0143
AC:
3130
AN:
218882
AF XY:
0.0139
show subpopulations
Gnomad AFR exome
AF:
0.0316
Gnomad AMR exome
AF:
0.0190
Gnomad ASJ exome
AF:
0.0125
Gnomad EAS exome
AF:
0.000124
Gnomad FIN exome
AF:
0.00383
Gnomad NFE exome
AF:
0.0172
Gnomad OTH exome
AF:
0.0202
GnomAD4 exome
AF:
0.0163
AC:
22254
AN:
1369394
Hom.:
217
Cov.:
23
AF XY:
0.0159
AC XY:
10906
AN XY:
684858
show subpopulations
African (AFR)
AF:
0.0281
AC:
890
AN:
31696
American (AMR)
AF:
0.0191
AC:
812
AN:
42464
Ashkenazi Jewish (ASJ)
AF:
0.0124
AC:
313
AN:
25316
East Asian (EAS)
AF:
0.000155
AC:
6
AN:
38630
South Asian (SAS)
AF:
0.00623
AC:
518
AN:
83160
European-Finnish (FIN)
AF:
0.00458
AC:
234
AN:
51074
Middle Eastern (MID)
AF:
0.0234
AC:
107
AN:
4572
European-Non Finnish (NFE)
AF:
0.0178
AC:
18416
AN:
1035278
Other (OTH)
AF:
0.0167
AC:
958
AN:
57204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1082
2164
3245
4327
5409
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0193
AC:
2941
AN:
152276
Hom.:
45
Cov.:
34
AF XY:
0.0183
AC XY:
1360
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0303
AC:
1258
AN:
41562
American (AMR)
AF:
0.0218
AC:
333
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00980
AC:
34
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00539
AC:
26
AN:
4826
European-Finnish (FIN)
AF:
0.00310
AC:
33
AN:
10630
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0172
AC:
1168
AN:
67998
Other (OTH)
AF:
0.0294
AC:
62
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
154
307
461
614
768
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00812
Hom.:
0
Bravo
AF:
0.0209
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 03, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.5
DANN
Benign
0.71
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76825716; hg19: chr21-47539065; COSMIC: COSV56011608; COSMIC: COSV56011608; API